At Schain Research, we leverage our deep knowledge in real-world evidence (RWE) to support drug development and optimize treatment outcomes across a wide range of therapeutic areas. Our work spans multiple disease areas, focusing on delivering high-quality data insights and innovative solutions tailored to each unique challenge. From oncology to neuroscience, our experience and access to comprehensive data sources enable us to contribute meaningfully to global health advancements.

Oncology

Supporting drug development in both hematological cancers and solid tumors like Bladder and Prostate Cancer.

Neuroscience

Experience in neurological conditions such as Multiple Sclerosis and Major Depressive Disorder.

Immunology

Expertise in autoimmune diseases and transplant rejection, including Graft-Versus-Host Disease.

Infectious Diseases

Real-world insights on infectious diseases like Dengue Fever, Ebola, and HIV.

Ophthalmology

RWE for vision-related diseases such as Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration.

Hematology

Real-world insights for benign hematological conditions such as warm Autoimmune Hemolytic Anemia (wAIHA), Sickle Cell Anemia, and Beta Thalassemia.

Jim Baker
Business Development
Executive

Are you curious to learn more about Schain Research?

Contact us. Get in touch today to learn
more about Schain Research and our services.